Cell Surface GRP94 as a Novel Emerging Therapeutic Target for Monoclonal Antibody Cancer Therapy

por Kim, Ji Woong, Cho, Yea Bin, Lee, Sukmook
Publicado 2021

Correction: Kim et al. Cell Surface GRP94 as a Novel Emerging Therapeutic Target for Monoclonal Antibody Cancer Therapy. Cells 2021, 10, 670

por Kim, Ji Woong, Cho, Yea Bin, Lee, Sukmook
Publicado 2021

Antibody-Based Targeting of Cell Surface GRP94 Specifically Inhibits Cetuximab-Resistant Colorectal Cancer Growth

por Jeoung, Mee Hyun, Kim, Taek-Keun, Kim, Ji Woong, Cho, Yea Bin, Na, Hee Jun, Yoo, Byong Chul, Shim, Hyunbo, Song, Dong-Keun, Heo, Kyun, Lee, Sukmook
Publicado 2019

Development and Characterization of Phage-Display-Derived Novel Human Monoclonal Antibodies against the Receptor Binding Domain of SARS-CoV-2

por Kim, Ji Woong, Min, Sung Won, Lee, Jichul, Shin, Ha Gyeong, Choi, Hye Lim, Yang, Ha Rim, Lee, Ji Hyun, Cho, Yea Bin, Shim, Hyunbo, Lee, Sukmook
Publicado 2022

A novel bispecific antibody dual-targeting approach for enhanced neutralization against fast-evolving SARS-CoV-2 variants

por Kim, Ji Woong, Kim, Hyun Jung, Heo, Kyun, Lee, Yoonwoo, Jang, Hui Jeong, Lee, Ho-Young, Park, Jun Won, Cho, Yea Bin, Lee, Ji Hyun, Shin, Ha Gyeong, Yang, Ha Rim, Choi, Hye Lim, Shim, Hyun Bo, Lee, Sukmook
Publicado 2023

Novel bispecific human antibody platform specifically targeting a fully open spike conformation potently neutralizes multiple SARS-CoV-2 variants

por Kim, Ji Woong, Heo, Kyun, Kim, Hyun Jung, Yoo, Youngki, Cho, Hyun-Soo, Jang, Hui Jeong, Lee, Ho-Young, Ko, In Young, Woo, Ju Rang, Cho, Yea Bin, Lee, Ji Hyun, Yang, Ha Rim, Shin, Ha Gyeong, Choi, Hye Lim, Hwang, Kyusang, Kim, Sokho, Kim, Hanseong, Chun, Kwangrok, Lee, Sukmook
Publicado 2023